South Wales, Dec. 1 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "REGENERON" on Nov. 19. The details about the trademark application no. UK00004297291 published in the journal no. 2025/048 (Nov. 28).
With Appleyard Lees IP LLP as representative, Regeneron Pharmaceuticals, Inc. filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Genetically modified cells, genome editing reagents, and biological preparations, namely, viral vectors, all for the treatment and/or prevention of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004297291
Disclaimer: Curated by HT Syndication.
